ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Benzene Exposure as a Risk Factor for Hematological Cancer or Related Disorders or Lung Cancer in Chinese Workers

This study is not yet open for participant recruitment.
Verified by National Cancer Institute (NCI), August 2007

Sponsored by: National Cancer Institute (NCI)
Information provided by: National Cancer Institute (NCI)
ClinicalTrials.gov Identifier: NCT00516568
  Purpose

RATIONALE: Exposure to low-level benzene in the work place may affect the risk of developing cancer later in life. Learning about the long-term effects of benzene exposure may help the study of cancer and related disorders in the future.

PURPOSE: This clinical trial is studying benzene exposure as a risk factor for hematological cancer or related disorders or lung cancer in Chinese workers.


Condition Intervention
Leukemia
Lung Cancer
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Diseases
Procedure: laboratory biomarker analysis
Procedure: polymorphism analysis
Procedure: questionnaire administration

Genetics Home Reference related topics:   aceruloplasminemia    hemophilia   

MedlinePlus related topics:   Cancer    Leukemia, Adult Acute    Leukemia, Adult Chronic    Lung Cancer    Lymphoma    Multiple Myeloma   

ChemIDplus related topics:   Salicylsalicylic acid    Sodium salicylate   

U.S. FDA Resources

Study Type:   Observational
Official Title:   A Case-Cohort Study of Hematopoietic Malignancies and Related Disorders and Lung Cancer in Benzene-Exposed Workers in China

Further study details as provided by National Cancer Institute (NCI):

Primary Outcome Measures:
  • Health risks from lower levels of benzene exposure

Estimated Enrollment:   3860

Detailed Description:

OBJECTIVES:

  • Evaluate health risks from lower levels of benzene exposure, particularly as present in factories during the 1990s.

OUTLINE: Participants complete questionnaires to collect information on potential confounders to the analysis of benzene's effects and information on work experience outside of the study cohort factories.

Patients undergo buccal cell and blood sample collection periodically for biological studies. Samples are analyzed for genetic polymorphisms potentially associated with benzene metabolism and disease status via polymorphism analysis.

  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

DISEASE CHARACTERISTICS:

  • Meets 1 of the following criteria:

    • Worker exposed to benzene

      • May be a patient with prior or concurrent benzene poisoning, lung cancer, or other malignancy
    • Relative (next of kin) of the worker
    • Control (no benzene exposure)

PATIENT CHARACTERISTICS:

  • Not specified

PRIOR CONCURRENT THERAPY:

  • Not specified
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00516568

Sponsors and Collaborators

Investigators
Study Chair:     Richard B. Hayes, DDS, PhD     National Cancer Institute (NCI)    
  More Information


Clinical trial summary from the National Cancer Institute's PDQ® database  This link exits the ClinicalTrials.gov site
 

Study ID Numbers:   CDR0000551706, NCI-06-C-N205
First Received:   August 14, 2007
Last Updated:   July 23, 2008
ClinicalTrials.gov Identifier:   NCT00516568
Health Authority:   Unspecified

Keywords provided by National Cancer Institute (NCI):
non-small cell lung cancer  
small cell lung cancer  
adult Hodgkin lymphoma  
adult T-cell leukemia/lymphoma  
anaplastic large cell lymphoma  
angioimmunoblastic T-cell lymphoma  
adult grade III lymphomatoid granulomatosis  
adult nasal type extranodal NK/T-cell lymphoma  
Waldenstrom macroglobulinemia  
adult Burkitt lymphoma  
adult diffuse large cell lymphoma  
adult diffuse mixed cell lymphoma  
adult diffuse small cleaved cell lymphoma  
adult immunoblastic large cell lymphoma  
adult lymphoblastic lymphoma  
grade 1 follicular lymphoma
grade 2 follicular lymphoma
grade 3 follicular lymphoma
mantle cell lymphoma
marginal zone lymphoma
small lymphocytic lymphoma
myelodysplastic syndromes
myelodysplastic/myeloproliferative diseases
adult acute lymphoblastic leukemia
adult acute myeloid leukemia
T-cell large granular lymphocyte leukemia
chronic lymphocytic leukemia
chronic myelogenous leukemia
chronic myelomonocytic leukemia
hairy cell leukemia

Study placed in the following topic categories:
Thoracic Neoplasms
Sezary syndrome
Chronic myelogenous leukemia
Chronic myelomonocytic leukemia
Hodgkin lymphoma, adult
Lymphoma, Mantle-Cell
Lymphoma, small cleaved-cell, diffuse
Lymphoma, large-cell, immunoblastic
Central nervous system lymphoma, primary
Lymphomatoid granulomatosis
Mycoses
Preleukemia
Hemorrhagic Disorders
Leukemia, Prolymphocytic
Multiple myeloma
Lung Neoplasms
Lymphoma, Large-Cell, Anaplastic
Acute myeloid leukemia, adult
Hodgkin Disease
Chronic lymphocytic leukemia
Myelodysplastic syndromes
Non-small cell lung cancer
Lymphoma, Large B-Cell, Diffuse
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Immunoproliferative Disorders
Hematologic Diseases
Leukemia, B-cell, chronic
Leukemia, Myelomonocytic, Chronic
Blood Coagulation Disorders
Acute myelogenous leukemia

Additional relevant MeSH terms:
Respiratory Tract Neoplasms
Neoplasms
Pathologic Processes
Disease
Neoplasms by Site
Neoplasms by Histologic Type
Immune System Diseases
Syndrome
Cardiovascular Diseases

ClinicalTrials.gov processed this record on October 07, 2008




Links to all studies - primarily for crawlers